Patents by Inventor Raymond F. Palmer

Raymond F. Palmer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Serum Biomarker Screen for the Diagnosis of Clinical and Preclinical Alzheimer's Disease
    Publication number: 20200271674
    Abstract: Certain embodiments are directed to methods of identifying dementia in subjects comprising, measuring serum levels of one or more of interferon gamma, IL-10, IL-12p40, IL-13, alpha 2 macroglobulin, beta 2 microglobulin, pancreatic polypeptide, prolactin, stem cell factor, thrombopoietin, and Von Willebrand Factor and identifying a subject as having dementia if the levels of the biomarkers is increased.
    Type: Application
    Filed: March 25, 2020
    Publication date: August 27, 2020
    Applicant: The Board of Regents of The University of Texas System
    Inventors: Donald R. Royall, Raymond F. Palmer
  • Serum biomarker screen for the diagnosis of clinical and preclinical alzheimer's disease
    Patent number: 10634687
    Abstract: Certain embodiments are directed to methods of identifying dementia in subjects comprising, measuring serum levels of one or more of interferon gamma, IL-10, IL-12p40, IL-13, alpha 2 macroglobulin, beta 2 microglobulin, pancreatic polypeptide, prolactin, stem cell factor, thrombopoietin, and Von Willebrand Factor and identifying a subject as having dementia if the levels of the biomarkers is increased.
    Type: Grant
    Filed: July 16, 2013
    Date of Patent: April 28, 2020
    Assignee: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Donald R. Royall, Raymond F. Palmer
  • Serum Biomarker Screen for the Diagnosis of Clinical and Preclinical Alzheimer's Disease
    Publication number: 20140018446
    Abstract: Certain embodiments are directed to methods of identifying dementia in subjects comprising, measuring serum levels of one or more of interferon gamma, IL-10, IL-12p40, IL-13, alpha 2 macroglobulin, beta 2 microglobulin, pancreatic polypeptide, prolactin, stem cell factor, thrombopoietin, and Von Willebrand Factor and identifying a subject as having dementia if the levels of the biomarkers is increased.
    Type: Application
    Filed: July 16, 2013
    Publication date: January 16, 2014
    Applicant: The Board of Regents of the University of Texas System
    Inventors: Donald R. Royall, Raymond F. Palmer